Guggenheim: Maintains Medpace Hldgs (MEDP.US) rating, adjusted from buy to buy rating, and adjusted target price from $453.00 to $464.00.
Zhitong FinanceApr 25 01:50
Medpace Hldgs Analyst Ratings
BenzingaApr 25 01:41
Medpace Hldgs Analyst Ratings
BenzingaApr 23 23:06
Jefferies Upgrades Medpace Hldgs to Buy, Raises Price Target to $450
BenzingaApr 23 23:08
Medpace Hldgs Analyst Ratings
BenzingaMar 18 20:15
Medpace Hldgs Analyst Ratings
BenzingaMar 9 01:07
UBS Adjusts Medpace Price Target to $480 From $452, Maintains Buy Rating
MT NewswiresMar 9 00:57
UBS Upgrades Medpace Hldgs to Buy, Raises Price Target to $452
BenzingaFeb 15 18:24
Medpace Hldgs Analyst Ratings
BenzingaFeb 15 03:03
Baird Maintains Outperform on Medpace Hldgs, Raises Price Target to $312
BenzingaJan 18 03:32
Medpace Hldgs Analyst Ratings
BenzingaJan 18 03:30
UBS Adjusts Medpace Price Target to $282 From $270, Maintains Neutral Rating
MT NewswiresOct 25, 2023 23:31
Medpace Holdings (NASDAQ:MEDP) Explodes Upward After Earnings, Analyst Weigh-In
TipRanksOct 25, 2023 00:02
Baird Upgrades Medpace Hldgs to Outperform, Raises Price Target to $289
BenzingaOct 24, 2023 18:17
Medpace Hldgs Analyst Ratings
BenzingaOct 24, 2023 18:15
Analysts Conflicted on These Healthcare Names: Medpace Holdings (MEDP) and Silk Road Medical (SILK)
TipRanksOct 24, 2023 16:40
UBS Adjusts Medpace Price Target to $270 From $215, Maintains Neutral Rating
MT NewswiresJul 26, 2023 23:38
Guggenheim Raises Medpace Holdings' Price Target to $273 From $252, Keeps Buy Rating
MT NewswiresJul 25, 2023 22:41
Medpace Hldgs Analyst Ratings
BenzingaJul 25, 2023 20:45
Guggenheim Upgrades Medpace Hldgs to Buy, Announces $252 Price Target
BenzingaMay 8, 2023 21:40
No Data
No Data